Effectiveness and safety of intravitreal aflibercept in patients with wet age-related macular degeneration treated in routine clinical practices across France: 12-month outcomes of the RAINBOW study

BACKGROUND/AIMS: To monitor treatment-naïve patients with wet age-related macular degeneration (wet AMD) receiving intravitreal aflibercept (IVT-AFL) in France. METHODS: RAINBOW (Real life use of intravitreal Aflibercept In FraNce - oBservatiOnal study in Wet age-related macular degeneration) is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Michel, Velasque, Laurent, Coscas, Florence, Faure, Céline, Aubry, Isabelle, Cohen, Salomon Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528760/
https://www.ncbi.nlm.nih.gov/pubmed/31179386
http://dx.doi.org/10.1136/bmjophth-2017-000109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528760/
https://www.ncbi.nlm.nih.gov/pubmed/31179386
http://dx.doi.org/10.1136/bmjophth-2017-000109

Ejemplares similares